We have generated a mouse carrying the human G551D mutation in the cys
tic fibrosis transmembrane conductance regulator gene (CFTR) by a one-
step gene targeting procedure, These mutant mice show cystic fibrosis
pathology but have a reduced risk of fatal intestinal blockage compare
d with 'null' mutants, in keeping with the reduced incidence of meconi
um ileus in G551D patients, The G551D mutant mice show greatly reduced
CFTR-related chloride transport, displaying activity intermediate bet
ween that of cftr(m1UNC) replacement ('null') and cftr(m1HGU) insertio
nal (residual activity) mutants and equivalent to similar to 4% of wil
d-type CFTR activity, The long-term survival of these animals should p
rovide an excellent model with which to study cystic fibrosis, and the
y illustrate the value of mouse models carrying relevant mutations for
examining genotype-phenotype correlations.